Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Silvio Danese, Séverine Vermeire, Wen Zhou, Aileen L. Pangan, Jesse Siffledeen, Susan Greenbloom, Xavier Hébuterne, Geert D'Haens, Hiroshi Nakase, Julian Panés, Peter D.R. Higgins, Pascal Juillerat, James O. Lindsay, Edward V. Loftus, William J. Sandborn, Walter Reinisch, Min Hu Chen, Yuri Sanchez Gonzalez, Bidan Huang, Wangang XieJohn Liu, Michael A. Weinreich, Remo Panaccione

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials'. Together they form a unique fingerprint.

Medicine & Life Sciences